Daniel GoldmanSell
MRVI · Transaction Apr 10, 2023 · Filed May 19, 2023 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · MRVI
+2.74% · +$0.2000 · Vol 3.7M
Market closed · last close 4:00 PM ET · price as of 19:57:30 ET
Maravai LifeSciences Holdings Inc
Life Sciences Tools & Services
$7.50
Veridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredWed Sep 2 · last completed session · Markets closed · resumes Thu 9:30 ET · MRVI
MethodologySentiment absence reason unknown
MRVI
Maravai LifeSciences Holdings Inc
Wed Sep 2 · last completed session · Markets closed · resumes Thu 9:30 ET
Upper range
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
72/ 100
Veridion Score
Upper range · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Wed Sep 2 · last completed session · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is MRVI moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Maravai LifeSciences Holdings Inc
PHARMACEUTICAL PREPARATIONSListed since
2020
Employees
415
Country
US
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$7.30
Day high
$7.61
Day low
$7.27
Previous close
$7.30
52W high
$9.00
-16.67% from high
52W low
$2.36
77% of range
Market cap
$1.1B
EPS
$-0.5500
Beta
0.56
Shares out
149M
Volume
3.7M
0.97× rel vol
Avg volume
3.8M
VWAP
$7.41
Price history computed in-house
1W
-10.39%
1M
+16.64%
3M
+49.40%
1Y
+217.80%
YTD
+130.77%
SMA 50 $6.73 · above
SMA 200 $4.47 · above
52W position 77%
MRVI overview
Related filings and maps
Public disclosures
Congress activity in MRVI
Official filing ↗
Federal contracts
MRVI contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MRVI in this window.
Lobbying spend
MRVI lobbying filings, year to date.
Registered lobbying filings matched to Maravai LifeSciences Holdings Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MRVI in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for MRVI.
Options
Sovereign unlock shows live options positioning for MRVI.